Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1733387 | 0.86 | CCR4 (0.52) | CCR4 | |
| SCHEMBL1732245 | 0.82 | CCR4 (0.79) | CCR4 | |
| SCHEMBL4704825 | 0.80 | CCR4 (0.44) | CCR4 | |
| SCHEMBL4704820 | 0.80 | CCR4 (0.44) | CCR4 | |
| SCHEMBL1733005 | 0.78 | CCR4 (0.53) | CCR4EDNRA | |
| SCHEMBL5907751 | 0.78 | CCR4 (0.50) | CCR4 | |
| SCHEMBL1733157 | 0.77 | CCR4 (0.51) | CCR4 | |
| SCHEMBL1733421 | 0.77 | CCR4 (0.56) | CCR4 | |
| SCHEMBL1732492 | 0.76 | CCR4 (1.00) | CCR4 | |
| SCHEMBL4699938 | 0.75 | CCR4 (0.39) | CCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467976-B1 | N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2011-11-23 | — | — | EP | disclosed |
| WO-2011081310-A3 | PEPTIDE MARKER FOR CANCER DIAGNOSIS, AND CANCER DIAGNOSIS METHOD USING SAME | 한국기초과학지원연구원 (KR) | 2011-10-27 | — | — | WO | disclosed |
| EP-1467976-A1 | N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES | AstraZeneca AB (SE) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003059893-A1 | N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2003-07-24 | — | — | WO | disclosed |